Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Return on Assets (2016 - 2025)

Lisata Therapeutics (LSTA) has disclosed Return on Assets for 11 consecutive years, with 0.78% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Assets fell 32.0% year-over-year to 0.78%, compared with a TTM value of 0.78% through Sep 2025, down 32.0%, and an annual FY2024 reading of 0.45%, changed N/A over the prior year.
  • Return on Assets was 0.78% for Q3 2025 at Lisata Therapeutics, down from 0.7% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.22% in Q2 2023 and bottomed at 0.78% in Q3 2025.
  • Average Return on Assets over 3 years is 0.45%, with a median of 0.41% recorded in 2024.
  • The sharpest move saw Return on Assets dropped -8bps in 2024, then crashed -32bps in 2025.
  • Year by year, Return on Assets stood at 0.33% in 2023, then plummeted by -66bps to 0.55% in 2024, then tumbled by -42bps to 0.78% in 2025.
  • Business Quant data shows Return on Assets for LSTA at 0.78% in Q3 2025, 0.7% in Q2 2025, and 0.6% in Q1 2025.